GlassScriptPhysician profile
Jay Richard Moore
NPI 1649256710
$1,443.94
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,417 · 2020: $14.23 · 2021: $13.14.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $215.14 | 2019 | |
| Novo Nordisk INC | $198.49 | 2019 | |
| Merck Sharp & Dohme LLC | $114.76 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.22 | 2019 | |
| Novartis Pharmaceuticals Corporation | $95.35 | 2019 | |
| Daiichi Sankyo INC. | $92.43 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.72 | 2019-2020 | |
| Lilly USA, LLC | $76.31 | 2019 | |
| Astellas Pharma US INC | $61.43 | 2019 | |
| Janssen Biotech, INC. | $53.02 | 2019 | |
| Janssen Pharmaceuticals, INC | $46.48 | 2019 | |
| Glaxosmithkline, LLC. | $45.10 | 2019 | |
| Allergan, INC. | $31.50 | 2019 | |
| Pfizer INC. | $27.08 | 2019 | |
| Mylan Specialty L.P. | $26.71 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $26.08 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.93 | 2019 | |
| Amgen INC. | $21.86 | 2019 | |
| Genentech USA, INC. | $19.87 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.89 | 2019 | |
| Circassia INC. | $14.02 | 2019 | |
| Phadia US INC. | $13.77 | 2019 | |
| Medtronic, INC. | $13.14 | 2021 | |
| Sanofi Pasteur INC. | $11.64 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.